3.920SEK-3.21%Mkt Cap: 433.65M SEKP/E: —Last update: 2026-06-01
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone forma…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap433.65M SEK
Enterprise Value278.71M SEK
Revenue (TTM)172.54M SEK
Gross Profit173.47M SEK
Net Income (TTM)-50.99M SEK
Revenue/Share1.768 SEK
Last Price3.920 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees35
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0012570448
Valuation
P/E (Trailing)—
P/E (Forward)-8.80
PEG—
EV/EBITDA-6.06
EV/Revenue1.62
P/S2.60
P/B1.50
EPS (TTM)-0.48
EPS (Forward)-0.46
52W Range
3.3354% of range16.72
52W High16.72 SEK
52W Low3.335 SEK
Profitability
Gross Margin96.29%
Oper. Margin-36.51%
EBITDA Margin-26.64%
Profit Margin-28.30%
ROE-16.45%
ROA-12.82%
Growth
Revenue Growth-17.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-64.03M SEK
CapEx (TTM)7.40M SEK
FCF Margin-24.23%
FCF Yield-9.64%
Net Debt-169.32M SEK
Net Debt/EBITDA3.68
Balance Sheet
Debt/Equity0.00
Current Ratio8.33
Quick Ratio7.28
Book Value/Sh2.702 SEK
Cash/Share1.541 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.400 SEK
Target Range5.100 SEK – 9.000 SEK
# Analysts3
Ownership
Shares Out.110.63M
Float78.05M
Insiders22.80%
Institutions26.24%
Technical
SMA 504.747 (-17.4%)
SMA 2009.463 (-58.6%)
Beta0.62
S&P 52W Chg27.70%
Avg Vol (30d)339.55K
Avg Vol (10d)284.53K
Technical Indicators
RSI (14)42.0
MACD-0.1343
MACD Signal-0.1952
MACD Hist.+0.0609
BB Upper4.364 SEK
BB Middle4.113 SEK
BB Lower3.862 SEK
BB Width12.20%
ATR (14)0.2393 SEK
Vol Ratio (20d)1.69x